According to a new study carried out by scientists from the University of North Carolina Lineberger Comprehensive Cancer Center and UNC Eshelman School of Pharmacy, laboratory research shows that stem cells can effectively deliver drugs to a medulloblastoma tumour site which is the most common paediatric brain tumour.
WideCells Group (LON:WDC) is a worldwide provider of stem cell services headquartered in Manchester, United Kingdom.
We are committed to making a difference in the world of family health protection; providing individuals and families access to affordable stem cell treatments globally.